Related references
Note: Only part of the references are listed.Age-related changes in the inflammatory responses to viral infections in the central nervous system during childhood
Sofia Ygberg et al.
PEDIATRIC RESEARCH (2022)
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)
A. Wollenberg et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Interleukin-33 and oxidative stress in epilepsy patients
Ozlem Ethemoglu et al.
EPILEPSY RESEARCH (2021)
Interleukin 4 deficiency limits the development of a lupus-like disease in mice triggered by phospholipids in a non-bilayer arrangement
Albany Resendiz-Mora et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2021)
Multifactorial expression of IL-6 with update on COVID-19 and the therapeutic strategies of its blockade (Review)
Elena Niculet et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis
Ai Kuzumi et al.
NATURE COMMUNICATIONS (2021)
Interleukin-31 Signaling Bridges the Gap Between Immune Cells, the Nervous System and Epithelial Tissues
Jana Maria Nemmer et al.
FRONTIERS IN MEDICINE (2021)
Interleukin-31 as a Clinical Target for Pruritus Treatment
Kenji Kabashima et al.
FRONTIERS IN MEDICINE (2021)
IL-33 as a Novel Serum Prognostic Marker of Intracerebral Hemorrhage
Ye Miao et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Therapeutic Opportunities of Interleukin-33 in the Central Nervous System
Yun Sun et al.
FRONTIERS IN IMMUNOLOGY (2021)
Intranasal delivery of interleukin-4 attenuates chronic cognitive deficits via beneficial microglial responses in experimental traumatic brain injury
Hongjian Pu et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2021)
Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson Disease
Zhaoqi Yan et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Basophils balance healing after myocardial infarction via IL-4/IL-13
Florian Sicklinger et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
IL-33 in Mental Disorders
Gianluca Pandolfo et al.
MEDICINA-LITHUANIA (2021)
Interleukin-13: Targeting an underestimated cytokine in atopic dermatitis
Thomas Bieber
ALLERGY (2020)
T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients
Laura Ghezzi et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Treatment of atopic dermatitis with ruxolitinib cream (JAKI/JAK2 inhibitor) or triamcinolone cream
Brian S. Kim et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
The Interleukin-33/ST2 axis promotes glioma mesenchymal transition, stemness and TMZ resistance via JNK activation
Lin Lin et al.
Aging-US (2020)
Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis
Giulia Gasparini et al.
CYTOKINE (2020)
IL-32γ suppressed atopic dermatitis through inhibition of miR-205 expression via inactivation of nuclear factor-kappa B
Yong Sun Lee et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
IL-13 Ameliorates Neuroinflammation and Promotes Functional Recovery after Traumatic Brain Injury
Wanying Miao et al.
JOURNAL OF IMMUNOLOGY (2020)
A key role for IL-13 signaling via the type 2 IL-4 receptor in experimental atopic dermatitis
Almog Bitton et al.
SCIENCE IMMUNOLOGY (2020)
Two single nucleotide polymorphisms in IL13 and IL13RA1 from individuals with idiopathic Parkinson's disease increase cellular susceptibility to oxidative stress
Carlos A. Aguirre et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma
Bodoor Yaseen et al.
RHEUMATOLOGY (2020)
Evaluating the Effect of Interleukin-4 in the 3xTg Mouse Model of Alzheimer's Disease
Dawling A. Dionisio-Santos et al.
FRONTIERS IN NEUROSCIENCE (2020)
IL-33/13 Axis and IL-4/31 Axis Play Distinct Roles in Inflammatory Process and Itch in Psoriasis and Atopic Dermatitis
Khaldon Bodoor et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2020)
IL-33 and its decoy sST2 in patients with Alzheimer's disease and mild cognitive impairment
Marina Saresella et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Hippocampal interleukin-33 mediates neuroinflammation-induced cognitive impairments
Flora Reverchon et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression
Astrid De Boeck et al.
NATURE COMMUNICATIONS (2020)
IL-4R alpha deficiency influences hippocampal-BDNF signaling pathway to impair reference memory
T. M. Brombacher et al.
SCIENTIFIC REPORTS (2020)
IL-33 Alleviated Brain Damage via Anti-apoptosis, Endoplasmic Reticulum Stress, and Inflammation After Epilepsy
Yuan Gao et al.
FRONTIERS IN NEUROSCIENCE (2020)
Epicardial Adipose Tissue and IL-13 Response to Myocardial Injury Drives Left Ventricular Remodeling After ST Elevation Myocardial Infarction
Valentina Parisi et al.
FRONTIERS IN PHYSIOLOGY (2020)
Peripheral levels of sST2 are increased in patients with temporal lobe epilepsy: Additional evidence of low-grade inflammation
Eliana Cristina de Brito Toscano et al.
EPILEPSY & BEHAVIOR (2020)
Early Treatment of Interleukin-33 can Attenuate Lupus Development in Young NZB/W F1 Mice
Fatin Nurizzati Mohd Jaya et al.
CELLS (2020)
Dupilumab for Atopic Dermatitis: The Silver Bullet We Have Been Searching for?
Ahsan Tameez Ud Din et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma
Hayato Okamoto et al.
SCIENTIFIC REPORTS (2019)
Systemic Sclerosis Pathogenesis and Emerging Therapies, beyond the Fibroblast
Andrea Sierra-Sepulveda et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Correlational study on altered epicardial adipose tissue as a stratification risk factor for valve disease progression through IL-13 signaling
Elena Vianello et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
Toll-like receptor-mediated inflammation markers are strongly induced in heart tissue in patients with cardiac disease under both ischemic and non-ischemic conditions
Victoria Rotter Sopasakis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
IL13RA2 Is Differentially Regulated in Papillary Thyroid Carcinoma vs Follicular Thyroid Carcinoma
Siao Ting Chong et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Peripheral Administration of IL-13 Induces Anti-inflammatory Microglial/Macrophage Responses and Provides Neuroprotection in Ischemic Stroke
Natalia Kolosowska et al.
NEUROTHERAPEUTICS (2019)
Elevated Gestational IL-13 During Fetal Development Is Associated With Hyperactivity and Inattention in Eight-Year-Old Children
Loreen Thuermann et al.
FRONTIERS IN IMMUNOLOGY (2019)
Combined Genetic Deletion of IL (Interleukin)-4, IL-5, IL-9, and IL-13 Does Not Affect Ischemic Brain Injury in Mice
Carlo Perego et al.
STROKE (2019)
IL-33/IL-31 Axis in Immune-Mediated and Allergic Diseases
Giuseppe Murdaca et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis
Mirko Manetti et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
IL33: Roles in Allergic Inflammation and Therapeutic Perspectives
Ben C. L. Chan et al.
FRONTIERS IN IMMUNOLOGY (2019)
Interleukin-13 in the pathogenesis of pulmonary artery hypertension
Shi-Min Yuan
JOURNAL OF LABORATORY MEDICINE (2019)
Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis
Paula Korhonen et al.
IBRO REPORTS (2019)
Peripheral inflammation in prodromal Alzheimer's and Lewy body dementias
Eleanor King et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
The role of interleukin-4 in rheumatic diseases
Chen Dong et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2018)
Association of interleukin 13 gene polymorphisms and plasma IL 13 level with risk of systemic lupus erythematosus
Rong Wang et al.
CYTOKINE (2018)
14-3-3z sequesters cytosolic T-bet, upregulating IL-13 levels in TC2 and CD8+ lymphocytes from patients with scleroderma
Sandra Cascio et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Reply to Happle R. et al. Koebner's sheep in Wolf's clothing: does the isotopic response exists as a distinct phenomenon?
L. C. Nwabudike et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
IL-33/IL-31 Axis: A Potential Inflammatory Pathway
Eleonora Di Salvo et al.
MEDIATORS OF INFLAMMATION (2018)
Critical Roles of IL-33/ST2 Pathway in Neurological Disorders
Mohammad Faruq Abd Rachman Isnadi et al.
MEDIATORS OF INFLAMMATION (2018)
IL-33/ST2 Pathway as a Rational Therapeutic Target for CNS Diseases
Li-Xia Du et al.
NEUROSCIENCE (2018)
Progress in our understanding of the pathogenesis of ankylosing spondylitis
Davide Simone et al.
RHEUMATOLOGY (2018)
Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development
Ilia D. Vainchtein et al.
SCIENCE (2018)
Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis
Chiara Rossi et al.
CELL DEATH & DISEASE (2018)
Tuning the Cytokine Responses: An Update on interleukin (IL)-4 and IL-13 Receptor Complexes
Ilkka S. Junttila
FRONTIERS IN IMMUNOLOGY (2018)
IL-31 is crucial for induction of pruritus, but not inflammation, in contact hypersensitivity
Ayako Takamori et al.
SCIENTIFIC REPORTS (2018)
An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis
Takashi Yamashita et al.
SCIENTIFIC REPORTS (2018)
Interleukin-4 Contributes to Degeneration of Dopamine Neurons in the Lipopolysaccharide-treated Substantia Nigra in vivo
Eugene Bok et al.
EXPERIMENTAL NEUROBIOLOGY (2018)
Interleukin 30 to Interleukin 40
Jovani Catalan-Dibene et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2018)
Expression and Function of IL-33/ST2 Axis in the Central Nervous System Under Normal and Diseased Conditions
Karen Fairlie-Clarke et al.
FRONTIERS IN IMMUNOLOGY (2018)
Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor
Vasiliki Liakouli et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Immunopathogenesis of Rheumatoid Arthritis
Gary S. Firestein et al.
IMMUNITY (2017)
Umbilicated Blue-Black Lesion on the Lateral Thorax
Alin Laurentiu Tatu
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2017)
IL-13-Mediated Regulation of Learning and Memory
Tiroyaone M. Brombacher et al.
JOURNAL OF IMMUNOLOGY (2017)
Lack of interleukin-13 receptor a1 delays the loss of dopaminergic neurons during chronic stress
Simone Mori et al.
JOURNAL OF NEUROINFLAMMATION (2017)
TH17 cells express ST2 and are controlled by the alarmin IL-33 in the small intestine
A. Pascual-Reguant et al.
MUCOSAL IMMUNOLOGY (2017)
Interleukin-13 reduces cardiac injury and prevents heart dysfunction in viral myocarditis via enhanced M2 macrophage polarization
Honghui Yang et al.
ONCOTARGET (2017)
IL-4 as a Repurposed Biological Drug for Myocardial Infarction through Augmentation of Reparative Cardiac Macrophages: Proof-of-Concept Data in Mice
Yusuke Shintani et al.
SCIENTIFIC REPORTS (2017)
IL-33 receptor ST2 regulates the cognitive impairments associated with experimental cerebral malaria
Flora Reverchon et al.
PLOS PATHOGENS (2017)
The ST2/IL-33 Axis in immune Cells during inflammatory Diseases
Brad Griesenauer et al.
FRONTIERS IN IMMUNOLOGY (2017)
Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease
Sachiko Furukawa et al.
SCIENTIFIC REPORTS (2017)
Behavioral Changes in Mice Lacking Interleukin-33
Eisuke Dohi et al.
ENEURO (2017)
Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients
G. Guggino et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress
Punniyakoti T. Veeraveedu et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Associations between Interleukin-31 Gene Polymorphisms and Dilated Cardiomyopathy in a Chinese Population
Huizi Song et al.
DISEASE MARKERS (2017)
MULTIPLE AUTOIMMUNE SYNDROME TYPE 3-THYROIDITIS,VITILIGO AND ALOPECIA AREATA
A. L. Tatu et al.
ACTA ENDOCRINOLOGICA-BUCHAREST (2017)
Experimental neurocysticercosis: absence of IL-4 induces lower encephalitis
Hidelberto Matos Silva et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2017)
Circulating levels of Th1 and Th2 chemokines in patients with ankylosing spondylitis
Jianing Wang et al.
CYTOKINE (2016)
IL-33 Is Selectively Expressed By Esophageal Basal Layer Epithelial Cells during Allergic Inflammation
Jared Travers et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Nuclear expression of IL-33 in epidermal keratinocyte is up-regulated in differentiated cells, while suppressed in proliferating cells
Mayumi Komine et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2016)
Recent advances in animal models of systemic sclerosis
Yoshihide Asano
JOURNAL OF DERMATOLOGY (2016)
IL-33 signaling is essential to attenuate viral-induced encephalitis development by downregulating iNOS expression in the central nervous system
Rafael F. O. Franca et al.
JOURNAL OF NEUROINFLAMMATION (2016)
The association of interleukin-31 polymorphisms with interleukin-31 serum levels and risk of systemic lupus erythematosus
Hua-Tuo Huang et al.
RHEUMATOLOGY INTERNATIONAL (2016)
Tumor growth suppressive effect of IL-4 through p21-mediated activation of STAT6 in IL-4Rα overexpressed melanoma models
Hye Lim Lee et al.
ONCOTARGET (2016)
IL33 in rheumatoid arthritis: potencial contribution to pathogenesis
Rafaela Bicalho Viana Macedo et al.
REVISTA BRASILEIRA DE REUMATOLOGIA (2016)
The Relationship of Cytokines IL-13 and IL-17 with Autoantibodies Profile in Early Rheumatoid Arthritis
Isabela Silosi et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system
Debbie Allan et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Elevated Serum Level of IL-33 and sST2 in Patients With Ankylosing Spondylitis
Xiao-lin Li et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Neuroimmunology of the Interleukins 13 and 4
Simone Mori et al.
BRAIN SCIENCES (2016)
IL-4 Modulates Macrophage Polarization in Ankylosing Spondylitis
Shishui Lin et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Soluble ST2 in heart failure
Benjamin Dieplinger et al.
CLINICA CHIMICA ACTA (2015)
Advances in pathogenesis and treatment of systemic sclerosis
C. P. Denton
CLINICAL MEDICINE (2015)
Critical role of IL-33 receptor ST2 in experimental cerebral malaria development
Jennifer Palomo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
IL-31 Induces Chemotaxis, Calcium Mobilization, Release of Reactive Oxygen Species, and CCL26 in Eosinophils, Which Are Capable to Release IL-31
Nikola Kunsleben et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33
Wei-Yu Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Increased Serum Levels of the IL-33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis
A. Wagner et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2015)
The Protective Role of Interleukin-33 in Myocardial Ischemia and Reperfusion Is Associated with Decreased HMGB1 Expression and Up-Regulation of the P38 MAPK Signaling Pathway
Ma Ruisong et al.
PLOS ONE (2015)
Hypoxia-induced mitogenic factor (FIZZ1/RELMα) induces endothelial cell apoptosis and subsequent interleukin-4-dependent pulmonary hypertension
Kazuyo Yamaji-Kegan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
Serum levels of the soluble IL-1 receptor family member ST2 and right ventricular dysfunction
Lucia Agoston-Coldea et al.
BIOMARKERS IN MEDICINE (2014)
Interleukin-13 Deficiency Aggravates Healing and Remodeling in Male Mice After Experimental Myocardial Infarction
Ulrich Hofmann et al.
CIRCULATION-HEART FAILURE (2014)
Plasma Soluble ST2 Levels Correlate With Disease Severity and Predict Clinical Worsening in Patients With Pulmonary Arterial Hypertension
Ya-Guo Zheng et al.
CLINICAL CARDIOLOGY (2014)
Endothelial dysfunction in systemic sclerosis
Nezam Altorok et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
Alzheimer's Disease: Evidence for the Expression of Interleukin-33 and Its Receptor ST2 in the Brain
Zhi Xiong et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
The effect of left ventricular remodelling on soluble ST2 in a cohort of hypertensive subjects
D. B. Ojji et al.
JOURNAL OF HUMAN HYPERTENSION (2014)
Human Th2 but Not Th9 Cells Release IL-31 in a STAT6/NF-κB-Dependent Way
Elisabeth Maier et al.
JOURNAL OF IMMUNOLOGY (2014)
Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome
Svitlana Demyanets et al.
PLOS ONE (2014)
IL-31 Associated with Coronary Artery Lesion Formation in Kawasaki Disease
Wan-Ning Tseng et al.
PLOS ONE (2014)
The Role of IL-33 in Rheumatic Diseases
Lihua Duan et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension
Guido Carlomagno et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Direct control of hepatic glucose production by interleukin-13 in mice
Kristopher J. Stanya et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Soluble ST2 predicts elevated SBP in the community
Jennifer E. Ho et al.
JOURNAL OF HYPERTENSION (2013)
Interleukin 33 Mediates Type 2 Immunity and Inflammation in the Central Nervous System of Mice Infected With Angiostrongylus cantonensis
Hui Peng et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
The role of markers of inflammation in traumatic brain injury
Thomas Woodcock et al.
FRONTIERS IN NEUROLOGY (2013)
A pro-fibrotic role for interleukin-4 in cardiac pressure overload
Peter Kanellakis et al.
CARDIOVASCULAR RESEARCH (2012)
IL-33 Independently Induces Eosinophilic Pericarditis and Cardiac Dilation ST2 Improves Cardiac Function
Eric D. Abston et al.
CIRCULATION-HEART FAILURE (2012)
Distribution and Clinical Correlates of the Interleukin Receptor Family Member Soluble ST2 in the Framingham Heart Study
Erin E. Coglianese et al.
CLINICAL CHEMISTRY (2012)
Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis
Dominique Talabot-Ayer et al.
JOINT BONE SPINE (2012)
IL-4 in the Brain: A Cytokine To Remember
Sachin P. Gadani et al.
JOURNAL OF IMMUNOLOGY (2012)
Cutting Edge: IL-13Rα1 Expression in Dopaminergic Neurons Contributes to Their Oxidative Stress-Mediated Loss following Chronic Peripheral Treatment with Lipopolysaccharide
Brad E. Morrison et al.
JOURNAL OF IMMUNOLOGY (2012)
Changes in the Monocytic Subsets CD14dimCD16+ and CD14++CD16- in Chronic Systolic Heart Failure Patients
Offer Amir et al.
MEDIATORS OF INFLAMMATION (2012)
Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population
Zaixing Yang et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2011)
Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis
Koichi Yanaba et al.
CLINICAL RHEUMATOLOGY (2011)
Angiotensin II-induced dilated cardiomyopathy in Balb/c but not C57BL/6J mice
Hongmei Peng et al.
EXPERIMENTAL PHYSIOLOGY (2011)
Role of IL-33 in inflammation and disease
Ashley M. Miller
JOURNAL OF INFLAMMATION-LONDON (2011)
Immune-inflammatory dysregulation modulates the incidence of progressive fibrosis and diastolic stiffness in the aging heart
Katarzyna A. Cieslik et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
The IL-33/ST2 pathway - A new therapeutic target in cardiovascular disease
Ashley M. Miller et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Local Macrophage Proliferation, Rather than Recruitment from the Blood, Is a Signature of TH2 Inflammation
Stephen J. Jenkins et al.
SCIENCE (2011)
Association of ST2 levels with cardiac structure and function and mortality in outpatients
Lori B. Daniels et al.
AMERICAN HEART JOURNAL (2010)
Plasma circulatory markers in male and female patients with coronary artery disease
Hem C. Jha et al.
HEART & LUNG (2010)
Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis
Phyllis Fung-Yi Cheung et al.
INTERNATIONAL IMMUNOLOGY (2010)
IL-31 A TH2 CYTOKINE INVOLVED IN IMMUNITY AND INFLAMMATION
M. L. Castellani et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2010)
Regulation of learning and memory by meningeal immunity: a key role for IL-4
Noel C. Derecki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Hypoxia-Induced Mitogenic Factor (HIMF/FIZZ1/RELMα) Increases Lung Inflammation and Activates Pulmonary Microvascular Endothelial Cells via an IL-4-Dependent Mechanism
Kazuyo Yamaji-Kegan et al.
JOURNAL OF IMMUNOLOGY (2010)
IL-33 Reduces Macrophage Foam Cell Formation
James E. McLaren et al.
JOURNAL OF IMMUNOLOGY (2010)
Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling
Kenjiro Seki et al.
CIRCULATION-HEART FAILURE (2009)
Cardiac Mast Cells Mediate Left Ventricular Fibrosis in the Hypertensive Rat Heart
Scott P. Levick et al.
HYPERTENSION (2009)
The complexity of managing systemic sclerosis: screening and diagnosis
M. Matucci-Cerinic et al.
RHEUMATOLOGY (2009)
Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation
Daniela Cihakova et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Structures and biological functions of IL-31 and IL-31 receptors
Qing Zhang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Nutrient intake and serum cytokine pattern in elderly people with heart failure
Girolamo Catapano et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
IL-33 reduces the development of atherosclerosis
Ashley M. Miller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
CNS-Derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells
Eugene D. Ponomarev et al.
JOURNAL OF NEUROSCIENCE (2007)
IL-33 and ST2 comprise a critical biomechanically induced and card ioprotective signaling system
Shoji Sanada et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling
Qianli Yu et al.
HYPERTENSION (2006)
Oncostatin M differentially regulates CXC chemokines in mouse cardiac fibroblasts
Pascal J. Lafontant et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
IL-13 signaling through the IL-13 alpha 2 receptor is involved in induction of TGF-beta 1 production and fibrosis
S Fichtner-Feigl et al.
NATURE MEDICINE (2006)
Serum markers of angiogenesis and myocardial ultrasonic tissue characterization in patients with dilated cardiomyopathy
T Ohtsuka et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27
S Pflanz et al.
JOURNAL OF IMMUNOLOGY (2004)
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
SR Dillon et al.
NATURE IMMUNOLOGY (2004)
IL-13 receptors and signaling pathways: An evolving web
GKK Hershey
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Interleukin 4 co-stimulates the PDGF-BB- and bFGF-mediated proliferation of mesangial cells and myofibroblasts
M Sommer et al.
NEPHRON (2002)
Expression and function of the ST2 gene in a murine model of allergic airway inflammation
K Oshikawa et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
IL-4 and IL-12 regulate proteoglycan-induced arthritis through stat-dependent mechanisms
A Finnegan et al.
JOURNAL OF IMMUNOLOGY (2002)
Decreased IL-4 producing CD4+ T cells in patients with active systemic lupus erythematosus-relation to IL-12R expression
K Sugimoto et al.
AUTOIMMUNITY (2002)
Localization of human interleukin 13 receptor in non-haematopoietic cells
M Akaiwa et al.
CYTOKINE (2001)
The increased interleukin-13 in patients with systemic lupus erythematosus: Relations to other Th1-, Th2-related cytokines and clinical findings
S Morimoto et al.
AUTOIMMUNITY (2001)
Share Paper
